Stock Report

All about this stock under one free report Last Updated: 27-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Sotac Pharmaceuticals Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SOTAC

₹90.05

₹0.00 (0.00%)

As on 26-Aug-2026 09:24IST

Market cap

info icon

₹100 Cr

Revenue (TTM)

info icon

₹97 Cr

P/E Ratio

info icon

17.3

P/B Ratio

info icon

1.8

Div. Yield

info icon

0.2 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- 1.13 -6.59 9.86 27.66
EBIT -- -15.14 87.96 24.78 83.82
Net Profit -- 34.16 159.14 47.70 154.13
EPS -- 34.16 87.48 26.65 131.73
Book Value -- -- 17.66 80.27 66.22
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-25Mar-24Mar-23
EBIT-Margin info 7.215.2410.115.026.50
Net Margin info 5.192.939.193.432.94
Return on equity info 19.777.4518.8312.9627.53
Return on Capital info 16.0414.7416.4010.2221.50
Return on Assets info 5.473.478.174.034.20
Debt to Equity (x) info ----0.820.552.21

Profitability

View Detailed Peer Comparison

ROCE

16.40

Higher than Peers by 1.68

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
16.40
10.22
21.50
31.31
-5.71
Peer Median
14.72
18.85
11.60
11.89
--
ROE

18.83

Higher than Peers by 7.16

Profit after tax / Average Net worth * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
18.83
12.96
27.53
63.16
-85.23
Peer Median
11.67
14.92
11.46
13.43
--
ROA

8.17

Higher than Peers by 0.32

Profit after tax / Average Total assets * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
8.17
4.03
4.20
8.23
-7.27
Peer Median
7.86
9.06
6.44
7.03
--
EBIT Margin

10.11

Lower than Peers by 4.92

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
10.11
5.02
6.50
6.90
-2.33
Peer Median
15.03
14.71
12.37
16.50
--
Net Margin

9.19

Lower than Peers by 0.13

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
9.19
3.43
2.94
3.92
-4.83
Peer Median
9.33
8.49
10.02
10.49
--
Cash Profit Margin

13.52

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
13.52
6.43
5.89
5.48
0.47
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

-6.59

Lower than Peers by 16.86

Year on year growth in net sales

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
-6.59
34.00
5.92
49.77
70.76
Peer Median
10.27
11.85
9.08
13.45
--
EBIT Growth

87.96

Higher than Peers by 63.82

Year on year growth in operating profit (EBIT)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
87.96
3.52
-0.15
543.63
-343.50
Peer Median
24.15
28.00
-3.12
18.27
--
Net Profit Growth

159.14

Higher than Peers by 128.84

Year on year growth in profit after tax

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
159.14
56.57
-20.58
221.70
-2,803.31
Peer Median
30.29
36.51
-0.85
27.20
--
EPS Growth

87.48

Higher than Peers by 62.98

Year on year growth in earnings per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
87.48
8.32
0.03
221.70
-2,803.31
Peer Median
24.50
--
-6.82
16.28
--
Book Value Growth

17.66

--

Year on year growth in book value per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
17.66
353.10
50.84
165.56
-18.44
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.82

Higher than Peers by 0.59

Total debt / Net worth

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
0.82
0.55
2.21
1.12
6.87
Peer Median
0.23
0.20
0.15
0.15
--
Short term debt to equity ratio

0.35

--

(Short term borrowings / Net worth)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
0.35
0.22
0.56
0.78
2.63
Peer Median
--
--
--
--
--
Current Ratio

1.35

Lower than Peers by 0.44

Current Assets / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
1.35
1.39
1.03
0.94
0.76
Peer Median
1.79
1.96
2.08
1.89
--
Quick Ratio

0.96

Lower than Peers by 0.50

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
0.96
0.98
0.73
0.74
0.55
Peer Median
1.47
1.44
1.58
1.64
--
Interest Coverage

5.31

Lower than Peers by 4.11

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
5.31
3.28
2.92
9.24
-1.01
Peer Median
9.42
8.58
15.41
15.38
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

35.17

Higher than Peers by 9.35

Debtors outstanding / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
35.17
25.32
19.02
16.75
12.05
Peer Median
25.82
26.12
22.96
20.72
--
Asset Turnover

0.85

Higher than Peers by 0.10

Sales / Average Total Assets

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
0.85
1.17
1.42
2.09
1.50
Peer Median
0.75
0.77
0.65
0.61
--
Receivable days

113.65

--

Average Debtors / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
113.65
72.11
63.58
45.25
47.99
Peer Median
--
--
--
--
--
Inventory Days

72.01

--

Average Inventory / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
72.01
55.63
44.84
25.51
26.72
Peer Median
--
--
--
--
--
Payable days

127.81

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
127.81
124.45
143.83
106.65
112.91
Peer Median
--
--
--
--
--
Cash Conversion Cycle

57.86

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
57.86
3.30
-35.41
-35.90
-38.19
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

16.35

Lower than Peers by 23.35

Current share price divided by earning per share in the last twelve months

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
16.35
31.23
--
--
--
Peer Median
39.70
33.48
37.74
60.11
--
Price / Book Value

2.46

Lower than Peers by 1.26

Current share price divided by book value per share in the latest financial year

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
2.46
2.95
--
--
--
Peer Median
3.72
4.21
3.22
3.92
--
Dividend Yield

0.08

Lower than Peers by 0.08

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
0.08
--
--
--
--
Peer Median
0.16
0.21
0.57
0.56
--
EV/EBITDA

9.89

Lower than Peers by 20.34

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
9.89
17.63
2.66
1.51
12.26
Peer Median
30.23
29.90
28.81
25.94
--
Market Cap

131

Lower than Peers by 4,720

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sotac Pharmaceuticals
131
134
--
--
--
Peer Median
4,851
2,099
15,272
13,501
--
loading...
loading...
loading...
loading...
loading...